Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals
- PMID: 33283554
- DOI: 10.1080/14737159.2021.1860760
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals
Abstract
Background: The SARS-CoV-2 pandemic introduced a global distraction effect in cancer patients' care. The aim of this study was to explore the effect of the pandemic on the largest molecular diagnostics center for cancer patients and high-risk individuals in Serbia.Research design and methods: EGFR, KRAS/NRAS, BRAF, and BRCA1/2 mutation testing were performed by qPCR and NGS. NGS was used for panel testing of hereditary breast/ovarian cancer and cancers associated with Lynch syndrome. The analytical output during the state of emergency (SoE) was compared to the period before and after the outbreak using one-way ANOVA. Statistical significance was set at p < 0.05.Results: A 38% reduction in the number of analysis was detected during the SoE. After the SoE, a 19% reduction was noted compared to SoE and 50% compared to the period before the SoE (p = 0.038). Three of the 48 scheduled appointments for pretest genetic counseling were carried out during the SoE, but the number of NGS tests increased by 50%.Conclusions: The SARS-CoV-2 pandemic had a profound negative effect on the diagnostic output of our centralized molecular diagnostics center. The only positive effect was shortening of waiting lists for hereditary cancer patients and high-risk individuals.
Keywords: Companion diagnostics; cancer genetics; genetic counseling; hereditary cancer; sars-CoV-2.
Similar articles
-
Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes.Exp Mol Pathol. 2021 Jun;120:104634. doi: 10.1016/j.yexmp.2021.104634. Epub 2021 Mar 25. Exp Mol Pathol. 2021. PMID: 33773991
-
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.Ann Oncol. 2019 Mar 1;30(3):439-446. doi: 10.1093/annonc/mdz005. Ann Oncol. 2019. PMID: 30689692
-
Molecular diagnosis in type I epithelial ovarian cancer.Ginekol Pol. 2017;88(12):692-697. doi: 10.5603/GP.a2017.0123. Ginekol Pol. 2017. PMID: 29303228 Review.
-
Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.Oncology. 2015;88(4):226-33. doi: 10.1159/000368836. Epub 2014 Dec 11. Oncology. 2015. PMID: 25503195
-
Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003. Obstet Gynecol Clin North Am. 2010. PMID: 20494261 Review.
Cited by
-
Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals.Sci Rep. 2023 Apr 17;13(1):6271. doi: 10.1038/s41598-023-33516-1. Sci Rep. 2023. PMID: 37069315 Free PMC article.
-
The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients.Therap Adv Gastroenterol. 2022 Aug 22;15:17562848221117636. doi: 10.1177/17562848221117636. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36035306 Free PMC article. Review.
-
Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.Dose Response. 2022 Aug 4;20(3):15593258221117354. doi: 10.1177/15593258221117354. eCollection 2022 Jul-Sep. Dose Response. 2022. PMID: 35958274 Free PMC article.
-
Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer.Dose Response. 2022 Jun 28;20(2):15593258221111666. doi: 10.1177/15593258221111666. eCollection 2022 Apr-Jun. Dose Response. 2022. PMID: 35783235 Free PMC article.
-
Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions.Medicina (Kaunas). 2022 Jan 10;58(1):100. doi: 10.3390/medicina58010100. Medicina (Kaunas). 2022. PMID: 35056408 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous